Siegfried Holding AG SFZN

Stock XSWX Rating as of Nov 12, 2026

CHF 70.35 −0.90 (1.26%)

View Full Chart

As of Nov 13, 2026, 3:25:41 PM Delayed Price Open

Company Report

View Archive

Narrow-Moat Siegfried's Strong Demand and Expanded US Capacity Support Long-Term Growth

Rachel Elfman Aug 24, 2026

Siegfried is a leading global contract development and manufacturing organization. It was founded in 1873 as the first pharmacy wholesaler and has reinvented itself several times since, evolving into a global player with advanced manufacturing facilities and lengthy customer relationships. Siegfried's growth over the last 14 years has allowed it to become a leading CDMO. Since 2010, sales have quadrupled, and the workforce has grown fivefold. The company has expanded from three manufacturing sites to 16 across four continents, and this scale has allowed it to further develop its contract manufacturing business.

Read Analysis

Price vs Fair Value

View History

SFZN is trading at a LOCK|%bx!b%! premium.

Price

CHF 71.25

Nov 12, 2026

Fair Value

LOCK|gH

Jul 24, 2024

Uncertainty

LOCK|w!j#b

1-Star Price: LOCK|&.K
5-Star Price: LOCK|.%
Economic Moat: LOCK|T?qF
Capital Allocation: LOCK|X!sbV&$

Bulls Say, Bears Say

Bulls

As drug manufacturing becomes more complex, the long-term outlook appears bright as biotechnology and pharmaceutical firms will be more reliant on outsourced manufacturing.

Bears

Siegfried is vulnerable to facility closures, whether from natural disasters or manufacturing issues. A warning letter from the FDA or another regulatory agency can result in manufacturing delays or closures.

Trading Information

Previous Close Price: CHF 71.25
Day Range: CHF 70.30–71.50
52-Week Range: CHF 65.05–101.60
Bid/Ask: CHF 70.25 / CHF 70.35
Shares Outstanding: 43.81M
Market Cap: CHF 3.08B
Volume/Avg: 31,171 / 113,003

Key Statistics

Price/Earnings (Normalized): 18.30
Price/Sales: 2.32
Dividend Yield (Trailing): 0.56%
Dividend Yield (Forward): 0.56%
Dividend Payment Schedule: Apr
Total Yield: 0.80%

Company Profile

Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 16 production sites on four continents.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Stock Style Box: Mid Core
Total Number of Employees: 4,454
Website: https://www.siegfried.ch

Competitors

Valuation

Metric	SFZN	ICLR	LONN
Price/Earnings (Normalized)	18.30	27.17	40.73
Price/Book Value	3.14	1.65	5.73
Price/Sales	2.32	1.87	7.38
Price/Cash Flow	13.14	16.71	23.80

Price/Earnings

SFZN

ICLR

LONN

Financial Strength

Metric	SFZN	ICLR	LONN
Quick Ratio	1.36	1.27	0.59
Current Ratio	3.45	1.32	1.66
Interest Coverage	24.55	3.49	9.29

Quick Ratio

SFZN

ICLR

LONN

Profitability

Metric	SFZN	ICLR	LONN
Return on Assets (Normalized)	7.56%	3.47%	6.27%
Return on Equity (Normalized)	15.73%	6.12%	13.97%
Return on Invested Capital (Normalized)	10.10%	5.69%	9.75%

Return on Assets

SFZN

ICLR

LONN

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen With Investor

Name	Capital Allocation	Economic Moat	Market Cap
Merck KGaA ADR MKKGY	LOCK\|q!%k>jv	LOCK\|!@Whr	$71B
Teva Pharmaceutical Industries Ltd TEVA	LOCK\|GF@#!sGR	LOCK\|dzGy	$51B
Haleon PLC ADR HLN	LOCK\|j$W!Ry	LOCK\|Sh	$40B
Zoetis Inc Class A ZTS	LOCK\|r#CJZ<w	LOCK\|r^!	$34B
Viatris Inc VTRS	LOCK\|F!K>&?	LOCK\|j%n	$24B
Elanco Animal Health Inc ELAN	LOCK\|nz	LOCK\|J%y	$13B
Dr Reddy's Laboratories Ltd ADR RDY	LOCK\|mkqVw$	LOCK\|Rlj	$12B
Hims & Hers Health Inc Ordinary Shares - Class A HIMS	LOCK\|$w>HmtW	LOCK\|T%#	$5B
Perrigo Co PLC PRGO	LOCK\|LPxWSF	LOCK\|@>&	$2B
Prestige Consumer Healthcare Inc PBH	LOCK\|v&KLQT	LOCK\|@$PJ>	$2B

Siegfried Holding AG SFZN

Company Report

Narrow-Moat Siegfried's Strong Demand and Expanded US Capacity Support Long-Term Growth

Price vs Fair Value

Bulls Say, Bears Say

Bulls

Bears

Trading Information

Key Statistics

Company Profile

Competitors

Valuation

Financial Strength

Profitability

Drug Manufacturers - Specialty & Generic Industry Comparables

Sponsor Center

What We Do

Company

Get Help